Sensus Healthcare Management

Management criteria checks 3/4

Sensus Healthcare's CEO is Joe Sardano, appointed in Jun 2010, has a tenure of 14.58 years. total yearly compensation is $687.60K, comprised of 65.4% salary and 34.6% bonuses, including company stock and options. directly owns 7.17% of the company’s shares, worth €7.79M. The average tenure of the management team and the board of directors is 3.5 years and 8 years respectively.

Key information

Joe Sardano

Chief executive officer

US$687.6k

Total compensation

CEO salary percentage65.4%
CEO tenure14.6yrs
CEO ownership7.2%
Management average tenure3.5yrs
Board average tenure8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Joe Sardano's remuneration changed compared to Sensus Healthcare's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$9m

Jun 30 2024n/an/a

US$7m

Mar 31 2024n/an/a

US$5m

Dec 31 2023US$688kUS$450k

US$485k

Sep 30 2023n/an/a

-US$896k

Jun 30 2023n/an/a

US$2m

Mar 31 2023n/an/a

US$6m

Dec 31 2022US$754kUS$400k

US$24m

Sep 30 2022n/an/a

US$27m

Jun 30 2022n/an/a

US$25m

Mar 31 2022n/an/a

US$21m

Dec 31 2021US$628kUS$375k

US$4m

Sep 30 2021n/an/a

-US$181k

Jun 30 2021n/an/a

-US$2m

Mar 31 2021n/an/a

-US$4m

Dec 31 2020US$510kUS$375k

-US$7m

Sep 30 2020n/an/a

-US$7m

Jun 30 2020n/an/a

-US$6m

Mar 31 2020n/an/a

-US$3m

Dec 31 2019US$467kUS$375k

-US$2m

Sep 30 2019n/an/a

-US$3m

Jun 30 2019n/an/a

-US$2m

Mar 31 2019n/an/a

-US$3m

Dec 31 2018US$538kUS$360k

-US$2m

Compensation vs Market: Joe's total compensation ($USD687.60K) is above average for companies of similar size in the German market ($USD463.17K).

Compensation vs Earnings: Joe's compensation has been consistent with company performance over the past year.


CEO

Joe Sardano (71 yo)

14.6yrs

Tenure

US$687,599

Compensation

Mr. Joseph C. Sardano, also known as Joe, serves as Director at BioFlorida Inc since August 2021. He Co-Founded Sensus Healthcare, Inc. in 2010 and has been its Chairman of the Board, Chief Executive Offic...


Leadership Team

NamePositionTenureCompensationOwnership
Joseph Sardano
Co-Founder14.6yrsUS$687.60k7.17%
€ 7.8m
Michael Sardano
President8yrsUS$452.53k0.70%
€ 761.4k
Javier Rampolla
Chief Financial Officer5yrsUS$357.06k0.25%
€ 266.8k
Magdalena Martinez
Chief Operating Officer2yrsno data0.060%
€ 64.7k
Emiliano Sosa
Chief Technology Officer2yrsno data0.061%
€ 66.3k
Stephanie Tipton
Vice President of Marketing2yrsno datano data

3.5yrs

Average Tenure

46yo

Average Age

Experienced Management: 5TX's management team is considered experienced (3.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Joseph Sardano
Co-Founder14.6yrsUS$687.60k7.17%
€ 7.8m
Michael Sardano
Presidentless than a yearUS$452.53k0.70%
€ 761.4k
Anthony Petrelli
Independent Director8.5yrsUS$75.00k0.41%
€ 440.7k
Brian Berman
Member of Medical Advisory Board8yrsno datano data
Angela Abbatecola
Member of Medical Advisory Boardno datano datano data
David Goldberg
Member of Medical Advisory Board8yrsno datano data
Kevin Schewe
Member of Medical Advisory Board7.9yrsno datano data
William McCall
Independent Director9.3yrsUS$75.00k0.18%
€ 198.9k
William Roth
Member of Medical Advisory Boardno datano datano data
Robert Beer
Member of Medical Advisory Board7.2yrsno datano data
Michael Gold
Member of the Medical Advisory Boardno datano datano data
Kenrick Spence
Member of Medical Advisory Boardno datano datano data

8.0yrs

Average Tenure

71yo

Average Age

Experienced Board: 5TX's board of directors are considered experienced (8 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/09 19:38
End of Day Share Price 2025/01/09 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sensus Healthcare, Inc. is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Andrew D'SilvaB. Riley Securities, Inc.
Alexander NowakCraig-Hallum Capital Group LLC
Ilya ZubkovFreedom Broker